No Data
No Data
No Data
No Data
No Data
Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic
Melodiol Global Health (ASX:ME1), through its subsidiary Health House Australia, is set to launch its medicinal cannabis clinic called the Health House Wellness Clinic in the second quarter of 2024, a
MT NewswiresApr 8 21:28 ET
Melodiol Global Health Posts 148% Increase in FY 2023 Revenue to AU$21.6 Million
Melodiol Global Health (ASX:ME1) has posted unaudited revenues of AU$3.1 million through February and ongoing total unaudited group revenue from all operations of AU$21.6 million in the 2023 financial
MT NewswiresMar 26 18:02 ET
Melodiol Unit to Add Cannabis Products Across Six Canadian Provinces
Melodiol Global Health's (ASX:ME1) Canadian subsidiary Mernova Medicinal reached agreements with six provincial governments in Canada to add more cannabis-related products during the first fiscal quar
MT NewswiresFeb 13 02:32 ET
Melodial's Unit Logs AU$1 Million Revenues in January
Melodiol Global Health (ASX:ME1) said its unit Health House International reported a revenue of AU$1 million in January. The revenue was generated from the medicinal cannabis company's established Aus
MT NewswiresFeb 7 00:56 ET
Melodiol Global's Canadian Arm Mernova Posts Record Sales for October
Melodiol Global Health (ASX:ME1) said Canadian subsidiary Mernova Medicinal has secured several purchase orders to "underpin" fiscal fourth-quarter revenue. The firm also said that the unit logged rec
MT NewswiresNov 2, 2023 08:56 ET
Melodiol Global Health Achieves 80% Remission Rate From Phase Two Hallucinogenic Trial
Melodiol Global Health (ASX:ME1) achieved an 80% remission rate from the first five patients treated in its phase two trial investigating the efficacy of the medical cannabis firm's Lucenex medication
MT NewswiresOct 11, 2023 22:04 ET
No Data
No Data